Artwork

内容由Talking About Tumors提供。所有播客内容(包括剧集、图形和播客描述)均由 Talking About Tumors 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

02_03 Adjuvant endocrine therapy for early breast cancer

31:30
 
分享
 

Manage episode 345612737 series 3335024
内容由Talking About Tumors提供。所有播客内容(包括剧集、图形和播客描述)均由 Talking About Tumors 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

1. Tamoxifen, its development, mechanism and benefits

2. Aromatase inhibitors and their benefit in post-menopausal state

3. Nuances on extended endocrine therapy beyond 5 years

4. SOFT/TEXT, a broad overview of a complex publication

Citations

As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.

DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.

Uptodate.com Waltham, MA: Wolters Kluwer.

Some highlighted references on this topic:

1. Pagani O et al.. NEJM. 2014;371(2):107-118. doi:10.1056/NEJMOA1404037

2. Francis PA et al. NEJM. 2018;379(2):122-137. doi:10.1056/NEJMOA1803164/

3. Gnant M et al. NEJM. 2021;385(5):395-405. doi:10.1056/NEJMOA2104162/

4. Cuzick J et al. Lancet Oncol. 2010;11(12):1135-1141. doi:10.1016/S1470-2045(10)70257-6

5. Regan MM et al. Lancet Oncol. 2011;12(12):1101-1108. doi:10.1016/S1470-2045(11)70270-4

6. Davies C et al.. The Lancet. 2013;381(9869):805-816. doi:10.1016/S0140-6736(12)61963-1

7. Goss PE et al. NEJM. 2016;375(3):209-219. doi:10.1056/NEJMOA1604700/

8. Goss PE et al. J Natl Cancer Inst. 2005;97(17):1262-1271. doi:10.1093/JNCI/DJI250

9. Abe O et al. The Lancet. 2011;378(9793):771-784. doi:10.1016/S0140-6736(11)60993-8

10. Jordan VC. A Breast Cancer Research. 2003;5(6):294. doi:10.1186/BCR656

Disclosures

Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.

Tags

Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology

  continue reading

45集单集

Artwork
icon分享
 
Manage episode 345612737 series 3335024
内容由Talking About Tumors提供。所有播客内容(包括剧集、图形和播客描述)均由 Talking About Tumors 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

1. Tamoxifen, its development, mechanism and benefits

2. Aromatase inhibitors and their benefit in post-menopausal state

3. Nuances on extended endocrine therapy beyond 5 years

4. SOFT/TEXT, a broad overview of a complex publication

Citations

As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.

DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.

Uptodate.com Waltham, MA: Wolters Kluwer.

Some highlighted references on this topic:

1. Pagani O et al.. NEJM. 2014;371(2):107-118. doi:10.1056/NEJMOA1404037

2. Francis PA et al. NEJM. 2018;379(2):122-137. doi:10.1056/NEJMOA1803164/

3. Gnant M et al. NEJM. 2021;385(5):395-405. doi:10.1056/NEJMOA2104162/

4. Cuzick J et al. Lancet Oncol. 2010;11(12):1135-1141. doi:10.1016/S1470-2045(10)70257-6

5. Regan MM et al. Lancet Oncol. 2011;12(12):1101-1108. doi:10.1016/S1470-2045(11)70270-4

6. Davies C et al.. The Lancet. 2013;381(9869):805-816. doi:10.1016/S0140-6736(12)61963-1

7. Goss PE et al. NEJM. 2016;375(3):209-219. doi:10.1056/NEJMOA1604700/

8. Goss PE et al. J Natl Cancer Inst. 2005;97(17):1262-1271. doi:10.1093/JNCI/DJI250

9. Abe O et al. The Lancet. 2011;378(9793):771-784. doi:10.1016/S0140-6736(11)60993-8

10. Jordan VC. A Breast Cancer Research. 2003;5(6):294. doi:10.1186/BCR656

Disclosures

Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.

Tags

Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology

  continue reading

45集单集

Semua episode

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南